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Abstract Current immunisation programmes against
hepatitisBvirus(HBV) increasinglyoften involve novel tri-
component vaccines containing—together with the small
(S-HBsAg)—also medium and large surface antigens of
HBV (M- and L-HBsAg). Plants producing all HBsAg
proteins can be a source of components for a potential oral
‘triple’ anti-HBV vaccine. The objective of the presented
research was to study the potential of M/L-HBsAg expres-
sion in leaf tissue and conditions of its processing for a
prototype oral vaccine. Tobacco and lettuce carrying M- or
L-HBsAg genes and resistant to the herbicide glufosinate
were engineered and integration of the transgenes was ver-
iﬁedbyPCRandSouthernhybridizations.M-andL-HBsAg
expression was conﬁrmed by Western blot and assayed by
ELISA at the level of micrograms per g of fresh weight. The
antigens displayed a common S domain and characteristic
domainspreS2andpreS1andwereassembledintovirus-like
particles (VLPs). Leaf tissues containing M- and L-HBsAg
were lyophilised to produce a starting material of an orally
administered vaccine formula. The antigens were distinctly
sensitive to freeze-drying conditions and storage tempera-
ture, in the aspect of stability of S and preS domains and
formation of multimeric particles. Efﬁciency of lyophilisa-
tion and storage depended also on the initial antigen content
in plant tissue, yet M-HBsAg appeared to be approximately
1.5–2 times more stable than L-HBsAg. The results of the
study provide indications concerning the preparation of two
other constituents, next to S-HBsAg, for a plant-derived
prototype oral tri-component vaccine against hepatitis B.
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Introduction
Recombinant vaccines against the hepatitis B virus (HBV),
based on the HBV small surface antigen (S-HBsAg) pro-
duced in yeasts, were introduced into hepatitis B (HepB)
vaccination programmes in the early 1980s. Although safe
and effective vaccines substantially provided prophylaxis
and control of HepB (Michel and Tiollais 2010), the
number of HBV chronic carriers and patients suffering
from HepB or hepatocellular carcinoma is still high (Kew
2010; Romano et al. 2011). Insufﬁcient medical infra-
structure and growing needs in many countries cause
delays in mass-scale HepB vaccination programmes. The
situation is deteriorating, also in developed countries, due
to mutated HBV strains, which can appear in response to
selection pressure caused by vaccination (Huang et al.
2004). Furthermore, a number of patients, mainly with
immunodeﬁciency syndromes and other ailments fail to
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DOI 10.1007/s00299-011-1223-7mount a sufﬁcient immune response following the appli-
cation of conventional vaccines, despite their 90–95%
effectiveness.
In the light of the above, research efforts have been
conductedtoproduceanovel,3rdgeneration,tri-component
vaccine, containing S-HBsAg and the other envelope
proteins of HBV, i.e. medium (M-HBsAg) and large
(L-HBsAg) surface antigens. All HBsAg proteins are enco-
dedwithinasingleopenreadingframeandcontainacommon
S domain. While S-HBsAg contains only the S domain,
M-HBsAg includes an additional preS2 fragment and
L-HBsAgconsistsofS,preS2andpreS1domains.S-HBsAg
assembles itself into stable and immunogenic virus-like
particles (VLPs) and is the basic constituent of the virus
envelope. The S fragment also anchors M and L antigens in
the lipid membrane and displays preS1 and preS2 domains.
These protruding epitopes form strongly immunogenic
determinants, apart from infectivity functions (Blanchet and
Sureau 2007). Consequently, preparations containing all
HBV surface antigens exhibit enhanced immunogenicity by
elicitingalargerspectrumofantiviralantibodies.Therefore,
tri-component vaccines are more effective than vaccines
based solely on S-HBsAg and they are gradually introduced
into immunisation programmes (Madalin ´ski et al. 2002;
Rendi-Wagner et al. 2006; Young et al. 2001).
However, it is impossible to produce M- and L-HBsAg
in bacteria and even in yeasts they need speciﬁc conditions
for expression (Brocke et al. 2005). Therefore, anti-HBV
novel vaccines require costly production in Chinese ham-
ster ovary (CHO) or other mammalian cell expression
systems and are too expensive for common use and remain
restricted to special cases. Yet, plant-based oral vaccines
are considered as alternatives or supplements for standard
injection vaccines, since they have the potential for cheaper
production and simpliﬁed vaccination procedures (Aziz
et al. 2007). So far, research on oral plant-based vaccines
against the HBV has focused mainly on the S-HBsAg. The
small HBV surface antigen was expressed in tobacco,
potato, lettuce and other species at a level of several up to
tens of lg/g fresh weight (FW), due to the formation of
stable VLPs (Huang et al. 2005; Kong et al. 2001; Pniewski
et al. 2011; Richter et al. 2000; Shulga et al. 2004). Anti-
HBs immune response, both in mice and humans, was
induced exclusively by oral administration of plant mate-
rial containing S-HBsAg (Kapusta et al. 1999, 2001;
Pniewski et al. 2011), although in most cases oral immu-
nisation was combined with the parenteral priming or
boosting using puriﬁed HBsAg (Joung et al. 2004; Kong
et al. 2001; Mason et al. 2003; Richter et al. 2000; Than-
avala et al. 2005). In comparison, M- and L-HBsAg were
expressed in plant systems, such as potato tubers or tomato
fruits, only in a few experiments and at levels of tens or
hundreds of ng/g FW (Ehsani et al. 1997; Lou et al. 2007;
Salyaev et al. 2010). Plant-associated M-HBsAg was also
able to induce some immune response after immunisation
conducted in oral priming and injection boosting patterns
(Joung et al. 2004; Youm et al. 2007). However, despite
some successes in laboratory experiments exploiting the
raw material, a potential mass-scale plant-derived oral
vaccine against HBV and other pathogens requires a for-
mulation based on lyophilised plant tissue (Huang et al.
2005; Pniewski et al. 2011; Webster et al. 2006) to facili-
tate and standardize specimen administration, improve
stability and immunisation effectiveness, and to some
extent control mucosal tolerance induction (Kirk et al.
2005; Mestecky et al. 2007).
We present here studies on M/L-HBsAg expression in
leaf tissue and their stability during processing and storage
of a prototype oral vaccine formula, as indispensable steps
prior to immunisation trials. Herbicide-resistant tobacco
and lettuce were engineered, stably expressing micrograms
of M- or L-HBsAg per g FW, which displayed domain S
and crucial domains preS2 and preS1 and were assembled
into VLPs or analogous aggregates. The inﬂuence of
freeze-drying together with storage temperature on lyoph-
ilised plant tissue was investigated in the aspect of S and
preS domain stability and assembly into multimeric
aggregates of M- and L-HBsAg. The results of the study
provide indications on the preparation of semi-products
containing M/L-HBsAg, which together with previously
obtained plant-associated S-HBsAg, can be used as con-
stituents of a plant-derived oral tri-component vaccine
against hepatitis B.
Materials and methods
Construction of plant transformation vectors
The coding sequences of M-HBsAg of 846 bp or L-HBsAg
of 1,170 bp in length were ampliﬁed on a template of the
plasmid pHB321 containing the complete genome of HBV
subtype ayw4 (GenBank: Z35716), using the following
primers: 50-GGATCCATGCAGTGGAACTCCACAAC-30
(forward for M-HBs sequence), 50-GGATCCATGATG
GGGCAGAATCTTTCC-30 (forward for L-HBs) and
50-CTGCAGTTAAATGTATACCCAAAGACAAAAGA-30
(reverse for both). The ampliﬁed fragments were cloned
using introduced BamHI and PstI restriction sites into the
pMG2A plasmid, a derivative of pUC18, containing the
35S RNA CaMV promoter (p35S) and the nopaline syn-
thase terminator (NOSt). The expression cassettes p35S-M/
LHBs-NOSt were cloned into the EcoRI and HindIII sites
of the pGPTV-BAR plasmid (Becker et al. 1992), replacing
the GUS gene. Constructed vectors pKHBMBAR or
pKHBLBAR (Fig. 1), carrying the bar gene conferring
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123resistance to glufosinate, were moved into the Agrobacte-
rium tumefaciens EHA105 strain via electroporation.
Plant transformation, regeneration and cultivation
Glufosinate-resistant lettuce plants were obtained accord-
ing to the previously described Agrobacterium-mediated
transformation procedure (Pniewski et al. 2011). Tobacco
leaf fragments were transformed using Agrobacterium
tumefaciens, according to a slightly modiﬁed routine pro-
cedure (Horsch et al. 1985). All stages of transformed
tobacco in vitro regeneration were conducted on selection
media, i.e. supplemented with 10 mg l
-1 of glufosinate
ammonium (Sigma, USA) and 300 mg l
-1 of timentin
(GlaxoSmithKline, Poland). Directly after co-culture with
Agrobacterium, explants were cultured on MST medium
consisting of MS salts and vitamins (Murashige and Skoog
1962), 3% (w/v) sucrose, 1 mg l
-1 BAP (6-benzylamm-
inopurine) and 0.1 mg l
-1 NAA (naphtaleneacetic acid).
Calli with adventitious buds were transferred onto the
MST1 medium consisting of MS salts and vitamins, 3%
(w/v) sucrose, 1 mg l
-1 KIN (kinetin) and 0.1 mg l
-1 IAA
(indole-3-acetic acid). Developed plantlets were rooted on
a half-strength MS medium.
In vitro cultures were conducted under 4,000 lx of light
intensity, 16/8 photoperiod and at a 25/18C temperature
regime. Rooted plantlets of tobacco and lettuce were
transferred into soil and grown in a greenhouse under
15–20 klx light intensity, 16/8 photoperiod and at a
22/16C temperature regime. Harvested seeds of lettuce
were germinated on the half-strength MS medium with 2.5
mg l
-1 glufosinate ammonium and seedlings of progeny
transformants were cultivated in soil as described above.
PCR and Southern blot analysis
Genomic DNA was extracted from leaves in a small-scale
procedure according to McGarvey and Kaper (1991).
Polymerase chain reactions were performed in a volume of
25 ll, containing approx. 100 ng of plant genomic DNA,
10 pM of each primer used for vector construction (see
above), 0.2 mM of each dNTP, 3.5 mM MgCl2 and 1 unit
of Taq DNA polymerase (Invitrogen, USA). HBsAg
sequences were ampliﬁed under the following temperature
proﬁle: initial denaturation at 94C for 4 min, next 35
cycles of denaturation at 94C for 1 min, annealing at 68C
for 45 s, elongation at 72C for 1 min, and ﬁnal extension
at 72C for 5 min. Plants were also screened by PCR for
the chvA gene to exclude false positive results caused by
residual contamination of Agrobacterium DNA, as descri-
bed previously (Pniewski and Kapusta 2005). Molecular
weight of PCR products was estimated by agarose gel
electrophoresis using the 200 bp DNA Ladder (MBI Fer-
mentas, EU).
DNA for Southern hybridization was extracted accord-
ing to Doyle and Doyle (1990), cut with the EcoRI, run on
0.75% agarose gel and then blotted onto a positively
charged membrane (Roche, USA). The probe speciﬁc to
the M- or L-HBs sequence was prepared by PCR using a
DIG labelling kit (Roche), hybridized according to the
manufacturer’s protocol and signals were detected on an
X-ray ﬁlm using CSPD (Roche) as a chemiluminescent
substrate.
Enzyme-linked immunosorbent assay (ELISA)
of M- and L-HBsAg
Contents of M- and L-HBsAg, both VLPs and total anti-
gens regarding the common S domain and characteristic
preS2 and preS1 domains, were assayed in tobacco and
lettuce leaves and in lyophilised tissue derived from lettuce
(see below). Tobacco individual plants were analysed at the
age of 6 months, i.e. shortly after adaptation to ex vitro
conditions past regeneration and after long-term (here
1 year) cultivation, i.e. at the age of 18 months. Lettuce
plants were analysed at generations T0 (primary transfor-
mants) and T1 (progeny transformants).
Samples were ground in a mortar on ice in a gradually
added extraction buffer consisting of PBS pH 7.4 (phos-
phate-buffered saline), 10 mM Na2SO3, 2% (w/v)
PVP40000 (polyvinylpyrrolidone MW 40,000), 0.2% (w/v)
BSA (bovine serum albumin) and supplemented with an
appropriate detergent. The detergents were respectively
0.05% (v/v) Triton X-100 or 1% (v/v) Tween
20, for M- or
L-HBsAg samples, and were experimentally selected from
among 0.02–2% (v/v) of Tween
20, SDS (sodium dodecyl
sulphate) and Triton X-100. Crude extracts were centri-
fuged for 10 min at 10,000 rpm at 4C. The ratio of the
extraction buffer volume to the sample weight was 25:1 for
leaves and 200:1 for lyophilised tissue.
Total M- or L-HBsAg contents were assayed by quan-
titative sandwich ELISA assays using mono- and
Fig. 1 Organization of T-DNA of binary plasmids pKHBMBAR and
pKHBLBAR. M/L-HBs coding sequence of surface antigen of HBV:
medium (preS2 and S domains) or large (preS1, preS2 and
S domains), in pKHBMBAR or pKHBLBAR, respectively; bar
coding sequence of phosphinothricin acetyltransferase; p35S CaMV
35S promoter, pNOS nopaline synthase promoter, NOSt nopaline
synthase terminator, g7t g7 terminator; LB and RB left and right
T-DNA border sequences
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123polyclonal antibodies, and performed according to typical
guidelines with details speciﬁc to a particular antigen.
A Microtiter MaxiSorp (NUNC, Denmark) microplate was
coated overnight with 0.5 lgm l
-1 of a monoclonal anti-
body (mAb) at 4C in carbonate buffer pH 9.6. Domains of
M- or L-HBsAg proteins were assayed using the following
mAbs: mAb C86123 M (Meridian Life Science, USA) for
the common S domain, mAb C8A031 M (Meridian Life
Science) for the preS2 domain characteristic of M-HBsAg
and mAb 5a-19 (kindly provided by Prof. Agata Bud-
kowska, Institut Pasteur, Paris, France) for the preS1
domain of L-HBsAg. The coated plate was saturated with
5% (w/v) PBS-fat-free milk at 25C for 1 h. Plant extracts
were added to PBS-ﬁlled wells and serially diluted. All the
following incubations with extracts or antibodies were
conducted at room temperature for 45 min. After sample
incubation, wells were incubated with 1:4,000 anti-HBsAg
domain S-speciﬁc polyclonal rabbit antibody (B65811R,
Meridian Life Science), then with 1:20,000 anti-rabbit IgG
c-speciﬁc biotin-conjugated mAb (Sigma), followed by
1:4,000 AP-conjugated ExtrAvidin
 (Sigma). The reaction
with pNPP substrate (Sigma) was developed at 25C for
1 h and absorbance was measured at 405 nm using a
Microplate Reader, Model 680 (Bio-Rad, USA). The
M- or L-HBsAg concentration was calculated in micro-
grams per gram of fresh weight (FW) or lyophilised mass,
respectively, as the arithmetic mean with standard devia-
tion (SD) from 3 to 6 repeated assays, using Microplate
Manager 5.2.1 software (Bio-Rad) according to the stan-
dard curve for CHO-derived M/L-HBsAg (kindly provided
by Prof. Reinhold Schirmbeck, University of Ulm,
Germany) diluted in the crude extract of a negative control
plant tissue.
For measurements of M- and L-HBsAg assembled into
VLPs or analogous aggregates, samples were assayed using
a monoclonal kit HBsAg Reagent v. 2.0 for IMx
 system,
module 3A3011 (Cat. No. 2228-22, Abbott, USA), speciﬁc
for the ‘a’ epitope displayed by all HBsAg proteins
assembled into VLPs. The samples were extracted as above
and assayed according to the provided protocol.
Western blot of M- and L-HBsAg
Leaf pieces, approx. 50–60 mg in weight, were ground in
300 ll of PBS with 0.5% (v/v) Tween
20, then Laemmli
buffer with DTT (dithiothreitol) was added and samples
were incubated at 65C for 15 min. Samples were run on
12% polyacrylamide gel with 0.1% (w/v) SDS and then
blotted onto a nitrocellulose membrane (Roche). The blot
was blocked with 3% (w/v) BSA in TBS (Tris-buffered
saline), then incubated with TBS-diluted 1 lgm l
-1
anti-preS2 mAb C8A031 M (Meridian Life Science) or
anti-preS1 mAb 5a-19 (Institut Pasteur). The 1:10,000
TBS-diluted anti-mouse whole-molecule polyclonal
AP-conjugated antibody (Sigma) was used as a secondary
antibody. The molecular weight of protein bands, visual-
ized after a reaction with the BCIP/NBT substrate (Sigma),
was estimated using a protein marker (MBI Fermentas).
Preparation, storage and analysis of lyophilised
plant material
Leaves from T1 generation lettuce plants, attributed to
particular HBsAg expression groups, were lyophilised
under experimentally selected conditions (see ‘‘Results’’
for details). Leaf tissue was frozen at -35C in a freezer
chamber and freeze-dried (BETA 1-16, CHRIST
, Ger-
many) in vacuum at 0.2 mbar, at a shelf temperature of
20C for 20 h in primary drying and 22C for 2 h in sec-
ondary drying. Lyophilised tissue was powdered in a coffee
mill chilled on ice and stored in the dark at 4, 22 (room
temperature) or 37C in tightly sealed bottles. Residual
moisture in the tissue was determined using the gravimetric
method (May et al. 1989). Contents of M- and L-HBsAg
were assayed (see above for details) directly after freeze-
drying had been completed (day 0) and after 30 and
90 days of storage.
Mean values of M/L-HBsAg content in the stored
lyophilised tissue, obtained for different temperatures and
diverse antigen content in source plants, were compared
statistically by analysis of variance, separately for three
antigen constituents (S and preS domains and VLP form)
and two times of assay (30 and 90 days). Homogeneous
groups of category combinations (HBsAg initial content in
source plants 9 temperature) for each antigen domain/
form with the largest mean values were identiﬁed using the
Fisher’s protected least signiﬁcant difference test (Genstat
14, VSN Int.).
Results
Expression of M- and L-HBsAg in tobacco
and lettuce plants
More than 100 regenerated glufosinate-resistant tobacco
plants were PCR-positive (Supplementary Fig. 1a, b) for
each transgene carrying M-HBs or L-HBs sequence
(Fig. 1), and T-DNA integration was conﬁrmed by South-
ern hybridizations (Supplementary Fig. 2a, b). Veriﬁed
plants initiated transgenic lines, where HBsAg expression
was analysed. Total contents of the antigens, both M- or
L-HBsAg, calculated in regard to the S domain, were
highly diverse among the transformants. Hence, they were
divided into three expression groups, with gradually
decreasing numbers of lines, i.e. of a ‘low’ antigen level
588 Plant Cell Rep (2012) 31:585–595
123\2 lg/g FW, ‘medium’ 2–10 lg/g FW and ‘high’[10 lg/g
FW (Fig. 2a, c), in which some tendencies of HBsAg
expression were more visible. The total content of
M-HBsAg was 1.3–1.4 times higher than for L-HBsAg.
This trend was even more distinct for the antigens assem-
bled in VLPs-analogous structures (for simpliﬁcation fur-
ther described as VLPs). The mean level of M-HBsAg
VLPs amounted to 51, 70 and 76% of the total antigen
content for the ‘low’, ‘medium’ and ‘high’ group, respec-
tively, and these ratios were maintained or slightly
decreased within the groups after long-term, here 18-month
cultivation period. However, the mean level of L-HBsAg
VLPs showed an opposite pattern—approx. 60% of the
total antigen content for the ‘low’ and the ‘medium’, in
contrast to 36% for the ‘high’ expressors, and it decreased
even twofold after a long-cultivation period.
Twenty-six PCR-positive, both for the M- and L-HBs
sequences, glufosinate-resistant transgenic lettuce lines (T0
generation) were obtained. The transgenes with HBs
sequences were transmitted to C75% of the progeny plants
(Supplementary Fig. 1c, d), which corresponded to the
inheritance of 1 or more T-DNA loci (Supplementary
Fig. 2c, d). Tendencies of HBsAg expression, revealed in
tobacco, were more evident in lettuce lines, also divided
into three expression groups (Fig. 2b, d). M-HBsAg was
expressed approx. 2 times more efﬁciently than L-HBsAg,
mainly in progeny plants (T1 generation), yet within
groups, especially in the ‘medium’ and ‘high’ ones, mean
contents of the antigens were lower than in tobacco. The
level of VLPs in T0 plants reached only 39, 26 and 10%
(M-HBsAg), or 27, 26 and 14% (L-HBsAg) of total antigen
contents, respectively, for the ‘low’, ‘medium’ and ‘high’
group. The contents of the antigens, particularly VLPs and
for L-HBsAg, dropped in T1 plants and the extent of
decrease was larger for ‘high’ expressors (Fig. 2b, d).
Despite a gradual deterioration of expression intensity,
the immunogenic VLP form of M- and L-HBsAg amounted
to 0.4–2.2 lg/g FW in lettuce and 0.4–12.8 lg/g FW in
tobacco (Fig. 2). Analyses using preS-speciﬁc mAbs
revealed characteristic preS2 or preS1 domains displayed
by the antigens. The total antigen contents calculated in
relation to preS2 or preS1 were consistent in C90% with
the basic S domain (Fig. 2). Antibodies speciﬁc to preS
fragments were also used in Western blot analyses of M-
and L-HBsAg in leaf extracts (Fig. 3). Despite some
background and weak non-speciﬁc signals, protein bands
of M- and L-HBsAg were clearly visible. Detected antigens
were of predicted size, both unmodiﬁed and putative gly-
cosylated forms, i.e. of 31 and 34 kDa for M-HBsAg and
39 and 42 kDa for L-HBsAg. Plant materials characterised
in the way described above were used for lyophilisation
experiments.
Lyophilisation of plant material containing
M- and L-HBsAg
Freeze-drying conditions of lettuce leaves expressing M- or
L-HBsAg were selected experimentally from among
combinations of the following parameters: freezing tem-
perature (liquid nitrogen, -35 and -20C), vacuum pres-
sure (0.1–0.4 mbar), temperature of primary and secondary
drying (5–22C) and duration (20–72 h). Differences in the
process yield were not large and reached max. 10% (data
not shown). However, the highest (Table 1), thus poten-
tially optimal, lyophilisation efﬁciency was observed for
freezing at -35C, drying at 0.2 mbar and at 20–22C for
22 h (see ‘‘Materials and methods’’ for details).
Efﬁciency of lyophilisation, considered as a relative
degree of HBsAg retention (assuming that dry mass is ca.
7% of fresh plant tissue as determined by gravimetric
method, detailed data not shown) was different for M- or
L-HBsAg and depended on the initial HBsAg content in
plant material (Table 1). The storage temperature of
lyophilised tissue combined with the initial antigen content
in source plants also exerted a marked and distinct effect on
M- or L-HBsAg preservation (Table 2).
The absolute content of freshly prepared freeze-dried
M-HBsAg was the highest in the material derived from
plants of the ‘high’ expression group, in regard to the S and
preS2 domains and VLPs. In contrast, the relative freeze-
drying efﬁciency of the S and preS2 domains decreased in
rank from ‘low’ to ‘high’ expressing plants; however,
VLPs were preserved in another manner (Table 1).
The content of long-term stored M-HBsAg, gradually
declined over time at all temperatures, in materials derived
from all plant expression groups (Table 2). The concentra-
tions of M-HBsAg were not statistically different only for S
domain after 30-day storage, but other trends were revealed
and maintainedafter90-daystorage.The preservation of the
antigen was the lowest at 4C, while 37C, besides 22C,
appeared to be advantageous for preS2 domain (Table 2).
However, for all other category combinations, i.e. antigen
contentinsourceplantsandtemperature(see‘‘Materialsand
methods’’), both after 30 and 90 days of storage, the com-
bination of high antigen initial content and 22C, appeared
in the group with the largest mean values (Table 2).
Therefore, this combination can be chosen as optimal for
processing and storage of plant-associated M-HBsAg, both
for S and preS2 domains and VLPs.
Lyophilisation and storage of plant tissue containing the
large surface antigen of HBV appeared different from
M-HBsAg in several aspects (Tables 1, 2). The absolute
content of total L-HBsAg directly after freeze-drying was
similar in all preparations derived from consecutive plant
expression groups. Therefore, the process efﬁciency for the
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from the ‘low’ group, and the lowest for the ‘high’ one.
Stability of VLPs corresponded generally with retaining of
the total antigen (Table 1).
During long-term storage of plant-associated L-HBsAg,
its particular domains and forms were preserved differently,
depending on temperature and the initial antigen content in
source plants (Table 2). However, concentrations of the
Fig. 2 Expression of VLPs and
total HBsAg in plants.
a Expression of M-HBsAg in
tobacco plants of 6- and
18-months of age, b expression
of M-HBsAg in lettuce plants of
T0 and T1 generation,
c expression of L-HBsAg in
tobacco plants of 6- and
18-months of age, d expression
of L-HBsAg in lettuce plants of
T0 and T1 generation. Plants
were divided into three
expression groups, depending
on total HBsAg content
calculated in lg/g of fresh
weight (FW): low\2 lg/g
FW, medium 2–10 lg/g FW
and high[10 lg/g FW. Level
of both VLP-assembled
antigens was determined by
monoclonal IMx
 diagnostic kit
(Abbott). Total contents of the
antigens were determined by
sandwich ELISA using anti-
HBsAg rabbit polyclonal
antibody (B65811R, Meridian
Life Science) and monoclonal
antibodies speciﬁc for S, preS2
or preS1 domains (respectively,
C86123 M and C8A031 M,
Meridian Life Science, and
5a-19, Institut Pasteur). Data
show values calculated as the
arithmetic mean and standard
deviation (SD) from three
assays
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123antigen were not statistically different on day 30 for S and
preS1domainsaswellasVLPs,soanychoiceofacategoryis
equally good on this date. The temperature of long-term
storage of plant-associated antigen exerted a distinct inﬂu-
ence regarding the S and preS1 domains and VLPs after
90-day storage period, although there was no combination
which was always in the group with the largest mean values.
L-HBsAg, particularly regarding preS1 domain and VLPs,
was the most stable in preparations obtained from plants of
the ‘low’ or ‘medium’ expression groups. Optimal temper-
ature for the preservation of the S domain of the antigen was
37C, while 22C for preS1 and 4C for VLPs (Table 2).
However,consideringthefactthatimmunogenicformofthe
antigenisVLPdisplayingpreS1domain,thecombinationof
medium L-HBsAg initial content and 4C seems to be a
good choice. In that variant, VLPs concentration is statisti-
cally higher in comparison to others as well as absolute
values of S and preS1 domains remain at reasonable level
(Table 2).
Although contents of both antigens in stored materials
gradually decreased, considering overall preservation of
the S and preS domains and VLPs, in the optimal variants
(see above) the antigens were maintained at the level of
several lg/g of lyophilised tissue (Table 2).
The storage temperature also distinctly affected a
reduction of residual moisture content of the lyophilised
plant material, as observed after a 90-day shelf life, from
the initial 4.1 to 3.8% at 4C, 2.3% at 22C and 0.2% at
37C, respectively.
Discussion
Tobacco was investigated to study the potential of M/L-
HBsAg stable expression in leaf tissue for its possible
exploitation as a bio-reactor producing antigens for a long
time, here 18 months, which would be puriﬁed and applied
Fig. 3 Western blot analysis of M-HBsAg in lettuce (a) and
L-HBsAg in tobacco (b) using monoclonal antibodies speciﬁc for
preS2 or preS1 domains. Lanes: M protein molecular weight marker
(MBI Fermentas), 1E/4–18A/8 or 2–28 analyzed lettuce or tobacco
plants, respectively, N non-transgenic plant (negative control),
P M-HBsAg or L-HBsAg, respectively (positive control, University
of Ulm, Germany). Arrows indicate non-glycosylated (p31 M-HBsAg,
p39 L-HBsAg) and putative glycosylated (gp34 M-HBsAg, gp42
L-HBsAg)proteinsofHBsAgantigens.M-andL-HBsAgproteinswere
detected using anti-preS2 (C8A031 M, Meridian Life Science) or anti-
preS1 (5a-19, Institut Pasteur) monoclonal antibodies
Table 1 Lyophilisation efﬁciency—antigens preserved directly after freeze-drying had been completed (day 0 of storage), in materials coming
from plants attributed to particular expression groups: low\2 lg/g FW, medium 2–10 lg/g FW and high[10 lg/g FW
Antigen Content in initial fresh tissue (lg/g) Antigen preservation in lyophilised tissue
Absolute content (lg/g) Relative content (%)
Low Medium High Low Medium High Low Medium High
M-HBsAg
S domain 1.8 4.2 9.8 24.5 26.1 34.2 94.3 43.6 24.5
preS2 domain 1.3 3.8 9.0 7.2 8.1 9.1 40.1 14.8 7.1
VLPs 0.4 0.8 1.1 0.8 5.5 14.6 13.2 48.2 93.8
L-HBsAg
S domain 1.0 3.1 5.7 13.3 16.2 15.9 94.2 37.2 19.6
preS1 domain 0.6 2.8 4.1 7.9 8.0 7.7 91.8 19.8 13.1
VLPs 0.3 0.5 0.2 3.8 2.3 1.2 95.9 33.9 38.2
Antigen content in fresh tissue is a mean from 6 to 8 plants of T1 generation used for lyophilisation; the antigen content in T1 generation
decreased in comparison to T0 generation, when expression groups were distinguished
Relative content calculated as a ratio of obtained value and theoretical value, if whole antigen would be preserved and assuming that dry mass
accounts for 7% of leaf fresh weight; dry mass determined using the gravimetric method (May et al. 1989)
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123as classical injection vaccines. At the same time, our
research was focused on lettuce, as the target species for
preparation of a prototype oral prophylactic vaccine. Let-
tuce is edible in the raw state, naturally free of harmful and
anti-nutritional substances and for an orally administered
vaccine the antigen concentration can be increased by
lyophilisation (Pniewski et al. 2011). Biomass of lettuce
leaves is relatively low, but they are easily freeze-dried in
comparison to tomatoes, tubers, carrot or bananas. Addi-
tionally, lettuce cultivation can be adapted to various
conditions and local needs.
Medium and large surface antigens of HBV were
expressed in leaf cells in the native and immunogenic
forms. The antigens displayed domain S, common for all
HBsAg proteins, and characteristic preS1 and preS2
domains and were assembled into VLPs or analogous
aggregates, as conﬁrmed by ELISA and Western blot
analyses using speciﬁc anti-preS monoclonal antibodies
and VLP-speciﬁc diagnostic kits (Figs. 2, 3).
Observation of M/L-HBsAg expression and its ﬂuctua-
tions in particular transgenic lines may suggest that the
antigens are not indifferent to plant cells. Accumulation of
M/L-HBsAg, especially their VLP or aggregate forms,
corresponded with the plant host, but the actual reasons of
lower expression efﬁciency in lettuce remain unknown.
However, both in lettuce and tobacco M-HBsAg was
synthesised more intensively than L-HBsAg. Probably, the
medium surface antigen is more durable in plant cells,
similarly to natural or recombinant expression systems
(Bruss 2007; Imamura et al. 1987). Both antigens contain
the S domain (226 aa), identical with the small surface
antigen (S-HBsAg), which anchors protein molecules in
the membrane and assembles them into dimers and fol-
lowing VLPs of 22 nm in diameter. However, preS frag-
ments, connected to the N-terminus of the S domain, are of
a different size. M-HBsAg displays only the preS2 domain
of 55 aa, while L-HBsAg exhibits preS2 together with the
preS1 domain consisted of 108–124 aa (here 108 aa).
Table 2 Mean values of M-HBsAg and L-HBsAg content in lyophilised tissue, grouped according to day of storage (30, 90) and antigen domain
(S domain, preS) or VLP form, with least signiﬁcant differences calculated for categories: combination of antigen content in source
plants 9 storage temperature
Day Antigen
domain/form
Temperature
(C)
M-HBsAg content (lg/g)
in tissue derived from
plant expression groups
LSD
(p = 0.05)
L-HBsAg content (lg/g)
in tissue derived from
plant expression groups
LSD
(p = 0.05)
Low Medium High Low Medium High
30 S 4 9.49 12.81 21.09 n.s. 6.68 6.42 9.15 n.s.
22 11.43 22.82 27.70 12.91 15.34 12.91
37 11.60 17.41 17.07 13.07 15.90 12.77
preS 4 0.04 0.15 0.08 1.71 2.78 4.00 2.66 n.s.
22 1.19 1.36 3.53
a 2.34 3.73 3.04
37 2.00
a 3.20
a 3.70
a 2.88 3.66 2.93
VLP 4 0.41 0.98 1.69 0.97 1.33 1.34 1.00 n.s.
22 0.70 1.35 5.79
b 1.35 1.16 1.14
37 0.60 1.53 3.80 1.40 1.32 1.12
90 S 4 0.80 2.39 3.41 7.05 2.39 2.88 1.00 3.54
22 10.40
c 14.98
c 14.98
c 7.32
a 5.13 2.56
37 6.35 7.47 10.09
c 9.43
a 10.11
a 9.43
a
preS 4 0.04 0.14 0.08 0.58 0.37 1.15 0.22 1.68
22 0.05 0.40 1.53
d 2.34
b 3.73
b 1.40
37 0.25 1.45
d 1.95
d 0.72 2.88
b 0.90
VLP 4 0.04 0.41 1.17 0.21 0.76
c 0.78
c 0.44 0.31
22 0.18 0.63 1.95
e 0.33 0.13 0.11
37 0.20 0.36 0.83 0.23 0.12 0.14
Categories with the largest means, determined according to the Fisher’s protected least signiﬁcant difference test, are marked by letter indexes,
separately for M- and L-HBsAg
LSD least signiﬁcant difference at p = 0.05; n.s. not signiﬁcant differences, here differences among nine combinations; preS preS2 for
M-HBsAg, preS1 for L-HBsAg
Antigen content in source plants attributed to expression groups: low\2 lg/g FW, medium 2–10 lg/g FW, high[10 lg/g FW
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123Although the structure of the preS1 epitope is still not
precisely known, joined preS domains of L-HBsAg are
larger and can make a spatial obstacle for quaternary
structure formation (Bruss 2007; Chi et al. 2006, 2007).
Thus, the medium antigen assembles into relatively stable
multimeric particles analogous to VLPs, while the large
antigen can probably form oligomeric aggregates, whereas
unstable VLPs are formed only under speciﬁc conditions
(Bruss 2007; Imamura et al. 1987; Yamada et al. 2001).
However, VLP-analogues (VLPs for simpliﬁcation) formed
by M- and L-HBsAg are signiﬁcantly less stable than the
actual VLPs of S-HBsAg. It could explain the several times
lower level of M/L-HBsAg VLPs, observed in this study as
well as previously (Ehsani et al. 1997; Joung et al. 2004;
Lou et al. 2007; Salyaev et al. 2010) in comparison to tens
of micrograms of S-HBsAg VLPs (Pniewski et al. 2011;
Richter et al. 2000). In accordance to lower stability of
VLPs assembled by M/L-HBsAg, the antigens exist mainly
in small-size forms, probably monomers or dimers, visu-
alised as the total antigen content excluding VLPs (Fig. 2).
Moreover, the percentage content of the antigens in VLP
structures, especially formed by L-HBsAg, adversely cor-
related with plant expression groups, as well as the total
antigen and VLP content reduced along with plant age or
generation (Fig. 2). Hence, it may be presumed that plant
cells can produce M- and especially L-HBsAg in their VLP
form, to a limited extent, ‘tolerable’ for cell integrity and
functionality, resembling the situation in HBV infected
cells (Bruss 2007). This supposition could also explain the
decreasing number of plant lines along with the increasing
expression level of the antigens. On the other hand, for-
mation of multi-particle structures inert for host cells and
still displaying whole or truncated preS1 regions, was
enhanced, but so far only in microorganisms. Mixed VLPs
were obtained in yeasts by co-expression of L-HBsAg and
S-HBsAg (Brocke et al. 2005). Another approach repre-
sents expression in E. coli of preS1N-terminal fragments,
crucial for infectivity and containing from 7 to 50 aa, fused
to carrier protein HBcAg (Chen et al. 2004). However,
specimens based on HBcAg can be used strictly for ther-
apy, not as prophylactic vaccines.
Despite ﬂuctuations of the expression, observed contents
of M- and L-HBsAg at the level of several lg/g FW were
essentially higher than the previously noted hundreds of
ng/g FW (Ehsani et al. 1997; Joung et al. 2004, Lou et al.
2007, Salyaev et al. 2010). A possible explanation for the
higher accumulation of M/L-HBsAg in lettuce or tobacco,
apart from the undeﬁned species effect, is that the antigens
were synthesized in leaves instead of potato tubers or
tomato fruits. It may be presumed that cell type and
metabolism could affect the M/L-HBsAg expression.
Regardless of reasons, the obtained values of M/L-HBsAg
concentrations were as high as those usually recorded for
S-HBsAg (Huang et al. 2005; Kong et al. 2001; Pniewski
et al. 2011; Richter et al. 2000; Shulga et al. 2004) and
were generally maintained after 18-month cultivation
(tobacco) or in the consecutive generation (lettuce). Con-
sequently, the resulting plant materials carrying M/L-HBsAg
seemed sufﬁcient for the next processing steps.
Tobacco could be utilized as a bio-reactor for long-term
and mass-scale production of the antigens. Yet, due to the
main goal of the project, only lettuce was directly used for
lyophilisation experiments as the ﬁrst step of conversion of
plant tissue into a prototype oral vaccine (Huang et al.
2005; Pniewski et al. 2011; Webster et al. 2006). We
decided to determine conditions of freeze-drying and
storage prior to immunisation trials, since antigen stability
is a fundamental factor of an efﬁcient immunisation
regime, including parameters such as deﬁned dosage and
administration timing.
Physiochemical transformations occurring during
freeze-drying and storage of lyophilised tissue differently
affected the S or preS domains of M- or L-HBsAg, as well
as their ability to maintain quaternary structures, i.e. VLPs
or aggregates. In general, hydrophilic preS domains were
more sensitive than the hydrophobic S domain, which
assembles into multimeric particles together with mem-
brane lipids (Table 1). Thus, it could be assumed that,
similarly as in fresh tissue, higher preservation of M than L
antigen resulted from the formation and stability of VLPs
versus oligomeric aggregates and a more durable structure
of the minor preS2 domain than the preS1 one (Bruss 2007;
Chi et al. 2006, 2007; Imamura et al. 1987; Yamada et al.
2001). The retention ratio of VLPs/aggregates during
freeze-drying was uppermost (M-HBsAg) or reasonably
high (L-HBsAg) for materials with an initial high content
of the antigens, while the relative preservation of the
antigens with preS domains was the most efﬁcient for
materials derived from plants classiﬁed to the ‘low’
expression group (Table 1). This observation may be
explained by dissimilar requirements of individual antigen
domains and molecules versus multimeric particles for
membrane lipids and water content affecting the hydration
shell.
The same phenomenon, but with a different effect,
turned out to be essential during storage of lyophilised
tissues. M-HBsAg, both small-size particles (mono- and
dimers) and VLPs, as well as the minor preS2 domain were
mainly preserved at 22C and more efﬁciently in materials
coming from ‘high’ expressors (see ‘‘Results’’ and
Table 2). The temperature of 37C could cause a loss of a
major part of indispensable structural water, while most of
residual water was retained at low storage temperature (see
‘‘Results’’), which was then probably conducive to gradual
degradation (Table 2). In the case of L-HBsAg, the most
likely requirement for a larger hydration shell of the joined
Plant Cell Rep (2012) 31:585–595 593
123preS1-preS2 domains differently affected antigen mono-
mers/dimers and aggregates. The ratio of the stored antigen
preservation was signiﬁcantly the highest for materials of
initial low and medium antigen contents (Table 2), where
residual water ‘supply’ was probably sufﬁcient. The small-
size L-HBsAg particles displaying the preS fragment were
stored at a satisfactory rate at higher temperatures, whereas
extended water retention at 4C seemed to be indispensable
for stabilization of aggregates. Probably residual water
formed not only a relatively thin hydration shell around
separate preS epitopes but also penetrated between them,
facilitating proper interactions and consequently main-
taining the structure of oligomeric aggregates with pro-
truding large preS epitopes (Table 2). Different
temperatures required for the preservation of preS domains
and aggregates of L-HBsAg pose an evident problem.
However, at this moment the resultant optimal storage
temperature for plant-associated L-HBsAg was found to be
4C, preferably for material derived from plants of the
‘medium’ expression group (see ‘‘Results’’, Table 2).
Despite the gradual degradation of lyophilised plant-
associated M/L-HBsAg during storage, antigenicity of both
proteins was preserved, including VLP forms and preS
domains, and in the optimal variants the antigen contents
were maintained at the level of several lg/g of tissue.
Presented results are 2–3 times lower in comparison to
S-HBsAg (Pniewski et al. 2011), but essentially higher than
previously observed for M-HBsAg (Salyaev et al. 2010),
and in the case of plant-expressed L-HBsAg this report is
the ﬁrst successful attempt at freeze-drying. We presume
that a potential plant-derived tri-component anti-HBV
vaccine could be prepared by a combination of separate
semi-products containing M- and L-HBsAg and previously
obtained S-HBsAg (Pniewski et al. 2011).
However, although at this moment the maintained
antigen contents in stored tissues seem sufﬁcient, oral
immunisation approaches using lyophilised tissue could be
performed only directly after the processing had been
completed, due to the subsequent gradual deterioration of
the stored material. Yet, a potential oral plant-derived
vaccine should be durable, according to the immunisation
procedures, which usually require 2–3 or more constant
antigen doses together with the associated plant tissue,
administered within several months. It was shown that
plant tissue is conducive to oral tolerance acquisition
(Kostrzak et al. 2009), hence an antigen should be stable to
avoid the administration of an increased dose of ‘ballast’
tissue. Therefore, we suspended animal immunisation trials
till sufﬁcient antigen stability (acceptable 10% ﬂuctuation)
would be achieved. Improved processing of plant tissue
bearing M/L-HBsAg can be accomplished using appro-
priate cryoprotectants, buffers, etc. We assume that not
only freeze-drying efﬁciency but also all antigen stability
during long-term storage at room temperature would be
enhanced, which is particularly important in the case of
L-HBsAg.
In conclusion, we showed a high accumulation of M/L-
HBsAg in plants, which consequently can be converted
into an oral vaccine. At the same time, presented data
indicate the importance of initial plant material for antigen
stability during lyophilisation and storage and problems
revealing concurrently with the processing. In this sense,
the results can be considered as a good starting point for
optimization experiments and advanced research on phys-
iochemical properties and immunogenecity of lyophilised
plant-associated M- and L-HBsAg. Nevertheless, the pre-
sented data show that the preparation of an oral plant-
derived tri-component anti-HBV vaccine is a realistic goal.
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